N
Google TrendMATTHEW STONE SR (200+) — Adult victims, suspected shooter ID'd in Erie mass shooting
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:matthew stone sr200+selma blair2000+al-nassr vs neftchi fergana5000+samantha busch500+crimson rescued mountain lion cub500+peggy flanagan200+sean combs10000+boeing 747500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Datroway Improves Surviva" (30 stories)

Top Headline Story

Datopotamab Deruxtecan Improves Survival Outcomes in Advanced Triple-Negative Breast Cancer
Lead StoryOncology Nursing Newsgeneral
Apr 30

Datopotamab Deruxtecan Improves Survival Outcomes in Advanced Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOX3hBZHkyY044bTBNQjJNRHRfbWkyYV82YUVQLWlxT0hoRnVIWW5PSEtLa3UwRGdybkN6NnU5ZjA4dzdTY2RDUVJPSVpHUHVSRE1EVkd6cWdCRzBrNmZ2TmpuU1NRNlpSbEQzNXZmeW1SaHJOdVh4QlAzQlg3TmdvWGxuMW80MTM4cDllRnRsM1dYZFBOel82aWwtSVB4MHVlVlpCNkJYelVtOUpkcUd2NVdPZFo5NzRDUmRLSTNkVnJmWUJQd1E?oc=5" target="_blank">Datopotamab Deruxtecan Improves Survival Outcomes in Advanced Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">Oncology Nursing News</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+21m ago

matthew stone sr

Adult victims, suspected shooter ID'd in Erie mass shooting

Filter stories
2000+41m ago

selma blair

Selma Blair arrested for biting flight attendant, trying to open plane door

Filter stories
5000+51m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

Filter stories
500+51m ago

samantha busch

Kyle Busch’s Widow Samantha Calls His Death ‘Unfair’ After ‘Emotional’ Celebration for Beloved NASCAR Star

Filter stories

Search Results for "Datroway Improves Surviva"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer
Cure Todaygeneral

FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOZ0hlMDQzaGZXOVVubFkwRzdVWkJXSEp4d0twbzlCNVNXUlg3WHNtNzNHRXoyN3NVM3Q4ME9KQ2NBUWl3aGRLemdsLUVPVDdodC0zTk16dHVMQkVydHV1Ql84YzMtTl9aUFpNUWtaMG1LNVFmVkc5RmM3S0lpdk9DNEtNQW9rTTlDYWVwdVhzbUNQdUR1V2J1MV8yd2Y1X29UZjM4cjBqMjZoeUJ5RVF3NE1NQXg?oc=5" target="_blank">FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
AstraZenecaworld

Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxPUjdseWhyQnRzd1NZS2huSmFKU0ZyZjZpZThGaU9DRlpPbF95dkk3SjBZdkpCdnZlZ205WWJwMERpaU1OenZoem00VFBYWU04VWRGNFl0bGMxakoyOUoyX2lkbDFtVFItRkppb1QtY0VuM3BWdWMtRE9qRk1BQUtNMlJoNWVHejJNOXE3NVo1TlRPeWtYazFNa0s2Zy1BWnhSVGtjdUE0T3RjZGdJYncwY2dpNzE1ZEJtOHZ4eFV2U2Y4eGRZVG5pdUNBam9YczhJUW9ZYXRybGppZmc?oc=5" target="_blank">Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy</a>  <font color="#6f6f6f">AstraZeneca</font>

Read Full StoryMore like this
How Long Can I Live With Triple-Negative Breast Cancer?
Verywell Healthgeneral

How Long Can I Live With Triple-Negative Breast Cancer?

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxNVWlaajBRQy0zQlZoMkhINURHUVA2UWtpc3FrSDl5YUlEd1p1SkJnbml6Rk15Z1lWN1kyVERIUmx6aHItMjl4WEVLcUFwbHZZNEVid2ZpOTRVSUFveURxMHNDTjF0U3pjVFFGM1R5SnVrclpIalktMEtrZGtsTVdOOGQyaGk?oc=5" target="_blank">How Long Can I Live With Triple-Negative Breast Cancer?</a>  <font color="#6f6f6f">Verywell Health</font>

Read Full StoryMore like this
Phase 3 Breast Cancer Breakthroughs, Misses, and More: Rapid News Roundup
Oncology News Centralworld

Phase 3 Breast Cancer Breakthroughs, Misses, and More: Rapid News Roundup

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNb1lSXzVvajB2cGsyUFphb3BOdEdzT3EtelB2MWx4bEYtOUVjYjJ5ZFA4Ti0yMmF0aENfazJuTWpSSks4RzcwdEktendPajQyc2JoV3lIY0g1VDBQWXZHNWJoLWhxbnNXa3ExMzJzTTlwUXZuZmQ3eE9VSWpaVnBfTWtBbUdKbFdVRGltTFYzd2YtTEVUYlVSNlJUM3RrcU82VzJHUEtOVlBFaTVzM0FZWnlLLW9SdkQzWjhMcw?oc=5" target="_blank">Phase 3 Breast Cancer Breakthroughs, Misses, and More: Rapid News Roundup</a>  <font color="#6f6f6f">Oncology News Central</font>

Read Full StoryMore like this
Datroway filed for TNBC in EU after data delay
pharmaphorumgeneral

Datroway filed for TNBC in EU after data delay

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE81WmlGUnFaQl9zcS1RNDZ6dkZtSW11Q0FZM3ZYZkxZVGF6U2tvZ3RkNGU4U0lVX1hvMm0xUUdKMDRra0VoY2dxQWZZbjlnSVpTMkdaUkQzTzNhdjVGc21iWFVXMXpHZlY2aFExMlRqaVFBa29VVG44Qw?oc=5" target="_blank">Datroway filed for TNBC in EU after data delay</a>  <font color="#6f6f6f">pharmaphorum</font>

Read Full StoryMore like this
AstraZeneca and Daiichi Sankyo’s Datroway given FDA Priority Review for breast cancer treatment
PMLiVEtech

AstraZeneca and Daiichi Sankyo’s Datroway given FDA Priority Review for breast cancer treatment

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPYWRSckRrTHNjMWg3dlM0T1pRMW5WTExCazVTdmo3QXJDNDFRcnk4VjlaV3hWenRPaHlheVA5S1REOVNLaVBnSVpQd3ZHcXRrbTdtc0R4TWJiR3F1NERHMGFJdmVyeC1QdkpiMWo5V0g0bnFrX3lZckRlODJ4U21ackVTVFl4NWlrRHJwX2tLV2t0Q2txOG0wWW9tb2NLU3VrTnBHR1ZDc0t2UEFqclJfeHRvMXYxTjQ?oc=5" target="_blank">AstraZeneca and Daiichi Sankyo’s Datroway given FDA Priority Review for breast cancer treatment</a>  <font color="#6f6f6f">PMLiVE</font>

Read Full StoryMore like this
AstraZeneca, Daiichi's Datroway improves survival in triple-negative breast cancer study
FirstWord Pharmatech

AstraZeneca, Daiichi's Datroway improves survival in triple-negative breast cancer study

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFB5dXBSaXZaSnQ4QWRaYk1tdDFQUE52OHRndHF6aXNCQ21ITXdnenpKNkJORHdmRnFuVWN0ZlpHTDdCZHlXWk85TkZjQTl6MEVlektN?oc=5" target="_blank">AstraZeneca, Daiichi's Datroway improves survival in triple-negative breast cancer study</a>  <font color="#6f6f6f">FirstWord Pharma</font>

Read Full StoryMore like this
TROPION-Breast02 Data Support Dato-DXd as New First-Line SOC in Triple-Negative Breast Cancer
OncLivegeneral

TROPION-Breast02 Data Support Dato-DXd as New First-Line SOC in Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOR2QtVGZ0aTFEOVljV0NEZjJnZGl3VWtRYUI1SFNtaHZleVlnazRDWlQ5dlFJZkpDb0RwckhWWktaRjlBYnNRRmZYRWFQRGZ0UXQ3N01FLWUtZ2llbkJReS1yY2piZU1ienRUUU1scTM3UnR2OVVXa2hZcm96c056Xzk2ZXhNUUZhR1ZTWE0yZ3lkbDFoenJqX082ZEpHcWl5b2VHcGJ5WUp1WjNvU2xtX1ZPM29qVXllMzU2QVFPSQ?oc=5" target="_blank">TROPION-Breast02 Data Support Dato-DXd as New First-Line SOC in Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
AstraZeneca and Daiichi's Datroway boosts overall survival in breast cancer trial
Reuterstech

AstraZeneca and Daiichi's Datroway boosts overall survival in breast cancer trial

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPaTZRdWh1RFBLU01pYmJ6a1JkN1hRc2lWRTdBWjhCQkFpRkNmalhPQXJLQ0VqTUQ1aGJaTGZqbjVZQjZrRXRoa3FhSUJnT05FZUM4VGVjU292cXI5R2lINnZUNVhqTElsdldJR2RqVTNQUDZkajdEY1kwVEhNV2N4RWZNSG5NTExwSFpVWFltR3BpTjhRT2QtWU8zYzdkbndWR3piVXlhemJ1dW91TWJNMEljb2ZDSldWZXlMejRibXY1Rk1maGRUODhJTlVScVh4ZlRhdA?oc=5" target="_blank">AstraZeneca and Daiichi's Datroway boosts overall survival in breast cancer trial</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
[ESMO 2025] ‘Datroway offers new alternative for triple-negative breast cancer unresponsive to immunotherapy’
Korea Biomedical Reviewworld

[ESMO 2025] ‘Datroway offers new alternative for triple-negative breast cancer unresponsive to immunotherapy’

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5vbU9kb19EV1JIWVZOYUVVWGdRRE45SWY4dXpWWVIxOXpoc0NKNE5pYXptdTh3VzYzakxwdlI2eVozWXF2aVowQUU2YmxSOG5oYzdpTjJtQmEzYUR2UXlVS1Z1ekd2MWFuWXhfRm930gFyQVVfeXFMTk1DaU5ySVhkTnBBaFpwc2ZLQ1FkZXhndWcwZFZIMlhiZjZ5czJHay1SSXpXNklGT3o1U1JuOWZ2a1U5OUlUUFp1bUp5aFgyZkFnNF95MGtuSEZLMFBBZTZobmtnUWgyUXBUaElsRng0OS1R?oc=5" target="_blank">[ESMO 2025] ‘Datroway offers new alternative for triple-negative breast cancer unresponsive to immunotherapy’</a>  <font color="#6f6f6f">Korea Biomedical Review</font>

Read Full StoryMore like this
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy
Business Wireworld

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy

<a href="https://news.google.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?oc=5" target="_blank">Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Dato-DXd Shows Promise as First-Line Therapy in Metastatic TNBC
Pharmacy Timesgeneral

Dato-DXd Shows Promise as First-Line Therapy in Metastatic TNBC

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOTkpPeGF0czlmZy1uVU9KelRFdU44Q2FZd241RnB4X0NqZVFaQ2FlV1psYm5teUtULTFTWEhPMUNiWC1xYUYzYmFueDdENEcxVkQ5RWxzc0xvc1FrSG9oZlRvOUZ4ZFNqdGx5bFhZSVFyOEFhX2tHRndCam5FVE9yT2NRYzl5RG95QlpKd1B2YW43dkUxaFFEenpTX2Zkam8?oc=5" target="_blank">Dato-DXd Shows Promise as First-Line Therapy in Metastatic TNBC</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Datroway demonstrated statistically significant and clinically meaningful improvement in overall survival as 1st-line therapy for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option in TROPION-Breast02
AstraZenecaworld

Datroway demonstrated statistically significant and clinically meaningful improvement in overall survival as 1st-line therapy for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option in TROPION-Breast02

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOenRLempVZUpFRzBRZVpNZ1FGRXlKdEpxQjdBb2RFbDhvd2R6Y2lNRmM1SjBjMXhaeUNBWVpvcmZ0N0dwcl9sbkhyS051blBaWGtkRFYyV3FjcF9wNzRVU0pyZnJ3OWhoTWpTX2sxQm1vR2tCOTd6NEw3SFZNZmhmQmNMNWhLSmhTVzVJRlh3WFRWRDNBRy1WYVNaMUZrNWVReUtpWmF1X3VzTlYzZFFMV1dUMUY?oc=5" target="_blank">Datroway demonstrated statistically significant and clinically meaningful improvement in overall survival as 1st-line therapy for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option in TROPION-Breast02</a>  <font color="#6f6f6f">AstraZeneca</font>

Read Full StoryMore like this
Dato-DXd Delivers Significant TNBC Survival Benefits in Phase 3 Trial
Targeted Oncologygeneral

Dato-DXd Delivers Significant TNBC Survival Benefits in Phase 3 Trial

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPSlpLQVlhNzkySzBvRTJSU216djNEdWpiWUZ3SHNDUWdyREZpTFEyd21ULWhmVmlsbzcyMmVDbS15bm5kaVFQNDRkNVZpdDBTUzNDaWhjTXd5clZNT1hBRVBNU0ltX1hETW94dHY4UXdlb3d3ZFk3ZjgxbnNBMHJBRDhCU0FmZFJSZTZVYlJKcGh2T3VBRVduQUg1bmtSd1pMU09fag?oc=5" target="_blank">Dato-DXd Delivers Significant TNBC Survival Benefits in Phase 3 Trial</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Datroway Improves Progression, Survival in Triple-Negative Breast Cancer
Cure Todaygeneral

Datroway Improves Progression, Survival in Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNOEFSQTVSTXV3RGhKMnN6S3RCVl9leWJHakpvR2J0aUhRZkF5UzNqOFdnWmhiUzctMUk5UTRyZ252dFB1cHdUM0NlMW5zNkZoV3FvcHZ1LTJzUlFKNUZpdFA5MjN2VmVxdDFWcTlOa0R3SkZsanlQUGpDRHJud3NibmxWTi0tMUpUU0IzT0NnSFV5RU1lS2t2MG55MFB2bG0wOUQ4bQ?oc=5" target="_blank">Datroway Improves Progression, Survival in Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
ESMO25: Datroway, Trodelvy deliver parallel wins in metastatic TNBC
FirstWord PHARMAgeneral

ESMO25: Datroway, Trodelvy deliver parallel wins in metastatic TNBC

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE9pYWR0a1FuQVIzMFVSZWhjd0VfRkZ0WTJULUNzWUVqQXBvcldEYW9CeHEyc09RRmlnRU5oekRWX19XM2RFYk5GV29UQW9HUG9fdTJF?oc=5" target="_blank">ESMO25: Datroway, Trodelvy deliver parallel wins in metastatic TNBC</a>  <font color="#6f6f6f">FirstWord PHARMA</font>

Read Full StoryMore like this
Delayed TNBC readout for Datroway delivers survival benefit
pharmaphorumgeneral

Delayed TNBC readout for Datroway delivers survival benefit

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNeS11bTB4ZThOcEtHelZkYmZhaEtoRUNOOURvak5HdWo0TFN5N2tIYVBJY01adEJWTzJmYkhBWlIwN2lSdGhWeTFKeDViY0c1YnhZQVQwOVdJbHRITzhiU21mX29FT0dsc3h3MnhtSnFpX2xrQ25PNnhLeDJWVXBjaENUVl9ad2ZGRHFQcEF3?oc=5" target="_blank">Delayed TNBC readout for Datroway delivers survival benefit</a>  <font color="#6f6f6f">pharmaphorum</font>

Read Full StoryMore like this
AstraZeneca's Datroway extends survival in aggressive breast cancer
Reutersgeneral

AstraZeneca's Datroway extends survival in aggressive breast cancer

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPeVNieDVGcnZlNlRjUHU4WnBNMjVGakdFRV9pang4U1ZfUnVVTzRUcHh1c21KSDYzbF8xZjFGWGtQNE1WSWpDYThXdGlTcTJxU3o4RldQdExNLXJRUWppRWlzVnNrSHpmZE42V1JQcldqeUQwSWUwb1owU1JDdko0cXRfWk9OTTJqcVFEYkV5blNaQW5DZWoxeU1RbGNJNkNZV2wwMkJuR1RPcXE5N1BiOG5GbGlrTlhQOFVyeVpCeGpFTGZmM1NNbllURlhHSHNF?oc=5" target="_blank">AstraZeneca's Datroway extends survival in aggressive breast cancer</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy
AstraZenecaworld

Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxORkMtVmt5U1Z1VVVZa2VhRk44Y1huQTFJZHY5bWhCRkhFMkhHS29ILTE2ek1nZjRueEhNSFVHdXRYS2VnQlMzV2V2a2dPYWFqMi1tMmowSHhzZ0pCTWdYSnowSTlfV2l3SWxHSXFFY1ZrSnJSZ0F5VkNVcGc0M2hPNXREZjVPYktHdFlMbEtzclZpSnl2aS1JRGFqUE9lNFk?oc=5" target="_blank">Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy</a>  <font color="#6f6f6f">AstraZeneca</font>

Read Full StoryMore like this
FDA Approves Datroway as First-Line Therapy for Triple-Negative Breast Cancer
Inside Precision Medicinegeneral

FDA Approves Datroway as First-Line Therapy for Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOdVdiTEJmMXdCN25oY3BEMFo4eFpPckVWN1NydHR0OWFCNWxpcDl5aXhxY19EWENucDlYN1o1SnpDcER6SkljdjZPRDlnUGw3cmZWUHNqRjJTNEc3U3RyRVdHdktoWFdEVlg5T1hCWHVWem03V0ZPdFV2VFJrekVuc2NIX3p6RVBoSHRfQmJpWThUdEo4Ym5NV0NYRXdsWnJXcnZ3Ym55NzU1NFRyN2cwR1ZkQURoT1hHYndNSUpLT0tienRjOWZlTjJ4alJpSDA?oc=5" target="_blank">FDA Approves Datroway as First-Line Therapy for Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Read Full StoryMore like this
Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer
AstraZenecaworld

Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNM1R6d0pPMnM4amtFOHY4TG1sVDRWaVJOQVhVaUJCbjl3WTFudmlOMHVXeHI3ZXRIdVhtX25Uc3NYZlZpNFNVbzRNMGdlSkU3QjdwYTVoRHVzUHdEQy0tbjdJZ3p6NW1hVy1ZVFVFUldGRGpRUDEyRlllVnloa2x3bURJX1JrSzJLUjlBLWFTM3Y2Yy1ldkM2QjUtQmhRMzRfdEZjd2dCLUdadFpZZGs0LXMwTm4?oc=5" target="_blank">Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer</a>  <font color="#6f6f6f">AstraZeneca</font>

Read Full StoryMore like this
AstraZeneca and Daiichi’s Datroway trumps chemo in first-line breast cancer
Clinical Trials Arenatech

AstraZeneca and Daiichi’s Datroway trumps chemo in first-line breast cancer

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPWHhtbFBveWRJR044NUdTZE0wa3dFamViMFdjMU5pNUdNVlVpVFhjOUd4NWxGcUgtWjRYRTR4ZUpPd3dsRFoxUElfdzNsaWtTUXBOcHdiY1plMVp1UmVKR2NJWjg5YjF0U09xdkJ0S2NkVlR3alg2SU5WOE4xRTYzcTVFNmhScE1NREJKLVVPeUhxMWZGRHpQMEpFRmoxZWxPUWhhWTZoUQ?oc=5" target="_blank">AstraZeneca and Daiichi’s Datroway trumps chemo in first-line breast cancer</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
DATROWAY® improved OS and PFS in TROPION-Breast02
Investing News Networkgeneral

DATROWAY® improved OS and PFS in TROPION-Breast02

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNNzlHb29HN0JlSTF6NTJtNWNWcHZ6QUFHRmhGdmxjRm04YXpobm5RbkdMUV8yb0k4eTk4Zm9kYzdNd2pDM0I1dXEySi12ZzVaNG5HZ3Y3QkZQQUZKRE5zblNpUnI1Xy1vOUw4djMzZml6ZXF5aWxtZGpfeS11dTZsMDc3OA?oc=5" target="_blank">DATROWAY® improved OS and PFS in TROPION-Breast02</a>  <font color="#6f6f6f">Investing News Network</font>

Read Full StoryMore like this
Antibody-Drug Conjugates Such As Datroway and Trodelvy May Transform TNBC
Cure Todaygeneral

Antibody-Drug Conjugates Such As Datroway and Trodelvy May Transform TNBC

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPanhUVVpEdkxBUXo1VjVDUHk2Rzhvb0ZteXRoYVJ4Uzd2QkxKM1Y3RFZTM0xXZURxV2ppcy1MY0pjMGFkenhoNUg5Y1pTcFhFU1AyZU4xNjcwM3ozWVFBLTh2NUpRM2dGSnUtVFZHOUFSeXNkaGEwRU1VSmhBb0x3d3BMd0lFTi1WTm0yRHZDMTBiR0ZqX2lpOEpPQWtoSUtWOHZMeTBQSQ?oc=5" target="_blank">Antibody-Drug Conjugates Such As Datroway and Trodelvy May Transform TNBC</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
FDA Approves Datroway as First-Line Treatment for Metastatic Triple-Negative Breast Cancer
Breast Cancer Research Foundationgeneral

FDA Approves Datroway as First-Line Treatment for Metastatic Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxQa2JIVlgzZTBtbV92LWVscVpmZk9zanRZVjJFT3YwR0tGNTFrQVFoWTFETGtsYU1PVlVQb1A2U1I3cXgxc1FCVWNZMXNHbG90amZFbnd5WFg1X0prdWdOV0VrTDQ1cWVKckN6M3N6a2FJajh5N1E2bk12YXlvZWJKcy1pQUJCbU9JWkE?oc=5" target="_blank">FDA Approves Datroway as First-Line Treatment for Metastatic Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">Breast Cancer Research Foundation</font>

Read Full StoryMore like this
Datroway: FDA Approves Antibody-Drug Conjugate Injection for Advanced Triple-Negative Breast Cancer
WebMDgeneral

Datroway: FDA Approves Antibody-Drug Conjugate Injection for Advanced Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxPZmxWUlRyeVVaRHJxQ1RJUXhCTHlFdWNocm1jVk43dGFXeHo2NWtaenBub0xiVEEzLXhFVHprVExDZDZsd2lXUGNIZmVsSEJxeGxIYmttTWl1OWdUdDNfZzF6WF9UZ1pMUTNaVWJ1Y0pYVlNCamdNYTAySzBFbnRrTEVVdmN1aHM?oc=5" target="_blank">Datroway: FDA Approves Antibody-Drug Conjugate Injection for Advanced Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">WebMD</font>

Read Full StoryMore like this
AstraZeneca and Daiichi's Datroway gets phase III breast cancer boost
European Pharmaceutical Reviewtech

AstraZeneca and Daiichi's Datroway gets phase III breast cancer boost

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNRkY0OS16TGdoWVhHcGQxaDNqeVdJSWtIRllaTlpUUUZZTEM3QlV5dlBsLUtoNjhPb29iS0dEU0NaTDMzT1gxUWNqZGJDSHBvWEtQOE5MbzJuaVhUVC1USFp3OVFKWnFOMzBHcnV5WlczZnljVG5uSnZmSEZKTTdZaGJUZDhTQ0pmT2M2VHpPOTN5RzZ3VkpqZk5NaXpOVktBcy1wek5hclBjbkF0Sl9ZV3FpbVVVS3RnbllTa0p6NkZvY1ZLRnp6cmF1UmxEZw?oc=5" target="_blank">AstraZeneca and Daiichi's Datroway gets phase III breast cancer boost</a>  <font color="#6f6f6f">European Pharmaceutical Review</font>

Read Full StoryMore like this
AZ, Daiichi score 'landmark' results for ADC Datroway in triple-negative breast cancer
Fierce Pharmatech

AZ, Daiichi score 'landmark' results for ADC Datroway in triple-negative breast cancer

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNWld4NllwNjFsV1VDaVZsV2JTc1JZX0I2NHAyXzlPaGpqR05rZnV4LXVGUjhRRHl5V2N0SzZpQTB3YndoUDVwNFNCZkJPMi1vb2JYdWJrWC0zN19GazRNZ0tjQ3hGVXhwa1ZwMTRVOTVKNl9kSTV1MV9mUGs0YTNrRVVoNFNXcFc3bVVxazZlTkc4SHctSWlsRkZGNHM1VGFtc2wwZ3h2VjRBQXhiNnQ5bUp3?oc=5" target="_blank">AZ, Daiichi score 'landmark' results for ADC Datroway in triple-negative breast cancer</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
BioSpacetech

AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNSERsMjFNSHBGeXZCSmYxTlJyN0NwZ1l3cEJNaXpUQXVfRENtUkdrVl8xbG4zY1dLTmNjcTJhWE51T0JWXzBfemdPblJKWXA3TDl0dWg0ZHRkYVI3U3poTDRVaGdxSVh4cjBaZk9wdzVJVjN2UjhkMkVmcXp0UUMtSjVFVXpFc05xVTBKUlduajl1WDZXUDhQdXB3Tzd0Zkdy?oc=5" target="_blank">AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
"Datroway Improves Surviva" — Live Google News Trends & Headlines